カテゴリ： 世界, 医療/バイオ, Market Monitor Global

口腔乾燥症治療薬のグローバル市場展望 2023年-2029年：OTC、処方薬

■ 英語タイトル：Xerostomia Therapeutics Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14521）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14521
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[口腔乾燥症治療薬のグローバル市場展望 2023年-2029年：OTC、処方薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の口腔乾燥症治療薬市場規模と予測を収録しています。・世界の口腔乾燥症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の口腔乾燥症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の口腔乾燥症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

口腔乾燥症治療薬のグローバル主要企業は、GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoatなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、口腔乾燥症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の口腔乾燥症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：タイプ別市場シェア、2022年
・OTC、処方薬

世界の口腔乾燥症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の口腔乾燥症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における口腔乾燥症治療薬のグローバル売上、2018年-2023年
・主要企業における口腔乾燥症治療薬のグローバル売上シェア、2022年
・主要企業における口腔乾燥症治療薬のグローバル販売量、2018年-2023年
・主要企業における口腔乾燥症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoat

*************************************************************

・調査・分析レポートの概要
口腔乾燥症治療薬市場の定義
市場セグメント
世界の口腔乾燥症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の口腔乾燥症治療薬市場規模
世界の口腔乾燥症治療薬市場規模：2022年 VS 2029年
世界の口腔乾燥症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの口腔乾燥症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の口腔乾燥症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、処方薬
口腔乾燥症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
口腔乾燥症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別口腔乾燥症治療薬市場規模 2022年と2029年
地域別口腔乾燥症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoat
...

This research report provides a comprehensive analysis of the Xerostomia Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Xerostomia Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Xerostomia Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Xerostomia Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Xerostomia Therapeutics market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Xerostomia Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Xerostomia Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Xerostomia Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Xerostomia Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Xerostomia Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., OTC, Prescription), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Xerostomia Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Xerostomia Therapeutics market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Xerostomia Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Xerostomia Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Xerostomia Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Xerostomia Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Xerostomia Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Xerostomia Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Xerostomia Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
OTC
Prescription
Market segment by Application
Hospital
Clinic
Other
Global Xerostomia Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GlaxoSmithKline plc
Church & Dwight Co., Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Outline of Major Chapters:
Chapter 1: Introduces the definition of Xerostomia Therapeutics, market overview.
Chapter 2: Global Xerostomia Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Xerostomia Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Xerostomia Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Xerostomia Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Xerostomia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Xerostomia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Xerostomia Therapeutics Overall Market Size
2.1 Global Xerostomia Therapeutics Market Size: 2022 VS 2029
2.2 Global Xerostomia Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Xerostomia Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top Xerostomia Therapeutics Players in Global Market
3.2 Top Global Xerostomia Therapeutics Companies Ranked by Revenue
3.3 Global Xerostomia Therapeutics Revenue by Companies
3.4 Global Xerostomia Therapeutics Sales by Companies
3.5 Global Xerostomia Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Xerostomia Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Xerostomia Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Xerostomia Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Xerostomia Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Xerostomia Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Xerostomia Therapeutics Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Prescription
4.2 By Type – Global Xerostomia Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Xerostomia Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Xerostomia Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
4.3 By Type – Global Xerostomia Therapeutics Sales & Forecasts
4.3.1 By Type – Global Xerostomia Therapeutics Sales, 2018-2023
4.3.2 By Type – Global Xerostomia Therapeutics Sales, 2024-2029
4.3.3 By Type – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
4.4 By Type – Global Xerostomia Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Xerostomia Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Xerostomia Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Xerostomia Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Xerostomia Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
5.3 By Application – Global Xerostomia Therapeutics Sales & Forecasts
5.3.1 By Application – Global Xerostomia Therapeutics Sales, 2018-2023
5.3.2 By Application – Global Xerostomia Therapeutics Sales, 2024-2029
5.3.3 By Application – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
5.4 By Application – Global Xerostomia Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Xerostomia Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Xerostomia Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Xerostomia Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Xerostomia Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
6.3 By Region – Global Xerostomia Therapeutics Sales & Forecasts
6.3.1 By Region – Global Xerostomia Therapeutics Sales, 2018-2023
6.3.2 By Region – Global Xerostomia Therapeutics Sales, 2024-2029
6.3.3 By Region – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Xerostomia Therapeutics Revenue, 2018-2029
6.4.2 By Country – North America Xerostomia Therapeutics Sales, 2018-2029
6.4.3 US Xerostomia Therapeutics Market Size, 2018-2029
6.4.4 Canada Xerostomia Therapeutics Market Size, 2018-2029
6.4.5 Mexico Xerostomia Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Xerostomia Therapeutics Revenue, 2018-2029
6.5.2 By Country – Europe Xerostomia Therapeutics Sales, 2018-2029
6.5.3 Germany Xerostomia Therapeutics Market Size, 2018-2029
6.5.4 France Xerostomia Therapeutics Market Size, 2018-2029
6.5.5 U.K. Xerostomia Therapeutics Market Size, 2018-2029
6.5.6 Italy Xerostomia Therapeutics Market Size, 2018-2029
6.5.7 Russia Xerostomia Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries Xerostomia Therapeutics Market Size, 2018-2029
6.5.9 Benelux Xerostomia Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Xerostomia Therapeutics Revenue, 2018-2029
6.6.2 By Region – Asia Xerostomia Therapeutics Sales, 2018-2029
6.6.3 China Xerostomia Therapeutics Market Size, 2018-2029
6.6.4 Japan Xerostomia Therapeutics Market Size, 2018-2029
6.6.5 South Korea Xerostomia Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia Xerostomia Therapeutics Market Size, 2018-2029
6.6.7 India Xerostomia Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Xerostomia Therapeutics Revenue, 2018-2029
6.7.2 By Country – South America Xerostomia Therapeutics Sales, 2018-2029
6.7.3 Brazil Xerostomia Therapeutics Market Size, 2018-2029
6.7.4 Argentina Xerostomia Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Xerostomia Therapeutics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Xerostomia Therapeutics Sales, 2018-2029
6.8.3 Turkey Xerostomia Therapeutics Market Size, 2018-2029
6.8.4 Israel Xerostomia Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia Xerostomia Therapeutics Market Size, 2018-2029
6.8.6 UAE Xerostomia Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Company Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Xerostomia Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline plc Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline plc Key News & Latest Developments
7.2 Church & Dwight Co., Inc.
7.2.1 Church & Dwight Co., Inc. Company Summary
7.2.2 Church & Dwight Co., Inc. Business Overview
7.2.3 Church & Dwight Co., Inc. Xerostomia Therapeutics Major Product Offerings
7.2.4 Church & Dwight Co., Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Church & Dwight Co., Inc. Key News & Latest Developments
7.3 Colgate-Palmolive Company
7.3.1 Colgate-Palmolive Company Company Summary
7.3.2 Colgate-Palmolive Company Business Overview
7.3.3 Colgate-Palmolive Company Xerostomia Therapeutics Major Product Offerings
7.3.4 Colgate-Palmolive Company Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 Colgate-Palmolive Company Key News & Latest Developments
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Company Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.5 Pendopharm
7.5.1 Pendopharm Company Summary
7.5.2 Pendopharm Business Overview
7.5.3 Pendopharm Xerostomia Therapeutics Major Product Offerings
7.5.4 Pendopharm Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Pendopharm Key News & Latest Developments
7.6 Sun Pharmaceuticals Industries Ltd.
7.6.1 Sun Pharmaceuticals Industries Ltd. Company Summary
7.6.2 Sun Pharmaceuticals Industries Ltd. Business Overview
7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Major Product Offerings
7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Sun Pharmaceuticals Industries Ltd. Key News & Latest Developments
7.7 Lupin Pharmaceuticals, Inc.
7.7.1 Lupin Pharmaceuticals, Inc. Company Summary
7.7.2 Lupin Pharmaceuticals, Inc. Business Overview
7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Major Product Offerings
7.7.4 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Lupin Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Company Summary
7.8.2 Pfizer, Inc. Business Overview
7.8.3 Pfizer, Inc. Xerostomia Therapeutics Major Product Offerings
7.8.4 Pfizer, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer, Inc. Key News & Latest Developments
7.9 Parnell Pharmaceuticals, Inc.
7.9.1 Parnell Pharmaceuticals, Inc. Company Summary
7.9.2 Parnell Pharmaceuticals, Inc. Business Overview
7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Major Product Offerings
7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Parnell Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Acacia Pharma
7.10.1 Acacia Pharma Company Summary
7.10.2 Acacia Pharma Business Overview
7.10.3 Acacia Pharma Xerostomia Therapeutics Major Product Offerings
7.10.4 Acacia Pharma Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Acacia Pharma Key News & Latest Developments
7.11 OraCoat
7.11.1 OraCoat Company Summary
7.11.2 OraCoat Business Overview
7.11.3 OraCoat Xerostomia Therapeutics Major Product Offerings
7.11.4 OraCoat Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 OraCoat Key News & Latest Developments
8 Global Xerostomia Therapeutics Production Capacity, Analysis
8.1 Global Xerostomia Therapeutics Production Capacity, 2018-2029
8.2 Xerostomia Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Xerostomia Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Xerostomia Therapeutics Supply Chain Analysis
10.1 Xerostomia Therapeutics Industry Value Chain
10.2 Xerostomia Therapeutics Upstream Market
10.3 Xerostomia Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Xerostomia Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Xerostomia Therapeutics in Global Market
Table 2. Top Xerostomia Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Xerostomia Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Xerostomia Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Xerostomia Therapeutics Sales by Companies, (K Units), 2018-2023
Table 6. Global Xerostomia Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Xerostomia Therapeutics Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Xerostomia Therapeutics Product Type
Table 9. List of Global Tier 1 Xerostomia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Xerostomia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Xerostomia Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Xerostomia Therapeutics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Xerostomia Therapeutics Sales (K Units), 2018-2023
Table 15. By Type - Global Xerostomia Therapeutics Sales (K Units), 2024-2029
Table 16. By Application – Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Xerostomia Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Xerostomia Therapeutics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Xerostomia Therapeutics Sales (K Units), 2018-2023
Table 20. By Application - Global Xerostomia Therapeutics Sales (K Units), 2024-2029
Table 21. By Region – Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Xerostomia Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Xerostomia Therapeutics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Xerostomia Therapeutics Sales (K Units), 2018-2023
Table 25. By Region - Global Xerostomia Therapeutics Sales (K Units), 2024-2029
Table 26. By Country - North America Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Xerostomia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Xerostomia Therapeutics Sales, (K Units), 2018-2023
Table 29. By Country - North America Xerostomia Therapeutics Sales, (K Units), 2024-2029
Table 30. By Country - Europe Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Xerostomia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Xerostomia Therapeutics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Xerostomia Therapeutics Sales, (K Units), 2024-2029
Table 34. By Region - Asia Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Xerostomia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Xerostomia Therapeutics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Xerostomia Therapeutics Sales, (K Units), 2024-2029
Table 38. By Country - South America Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Xerostomia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Xerostomia Therapeutics Sales, (K Units), 2018-2023
Table 41. By Country - South America Xerostomia Therapeutics Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Xerostomia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Xerostomia Therapeutics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Xerostomia Therapeutics Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline plc Company Summary
Table 47. GlaxoSmithKline plc Xerostomia Therapeutics Product Offerings
Table 48. GlaxoSmithKline plc Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline plc Key News & Latest Developments
Table 50. Church & Dwight Co., Inc. Company Summary
Table 51. Church & Dwight Co., Inc. Xerostomia Therapeutics Product Offerings
Table 52. Church & Dwight Co., Inc. Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Church & Dwight Co., Inc. Key News & Latest Developments
Table 54. Colgate-Palmolive Company Company Summary
Table 55. Colgate-Palmolive Company Xerostomia Therapeutics Product Offerings
Table 56. Colgate-Palmolive Company Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Colgate-Palmolive Company Key News & Latest Developments
Table 58. Hikma Pharmaceuticals PLC Company Summary
Table 59. Hikma Pharmaceuticals PLC Xerostomia Therapeutics Product Offerings
Table 60. Hikma Pharmaceuticals PLC Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 62. Pendopharm Company Summary
Table 63. Pendopharm Xerostomia Therapeutics Product Offerings
Table 64. Pendopharm Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Pendopharm Key News & Latest Developments
Table 66. Sun Pharmaceuticals Industries Ltd. Company Summary
Table 67. Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Product Offerings
Table 68. Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sun Pharmaceuticals Industries Ltd. Key News & Latest Developments
Table 70. Lupin Pharmaceuticals, Inc. Company Summary
Table 71. Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Product Offerings
Table 72. Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Lupin Pharmaceuticals, Inc. Key News & Latest Developments
Table 74. Pfizer, Inc. Company Summary
Table 75. Pfizer, Inc. Xerostomia Therapeutics Product Offerings
Table 76. Pfizer, Inc. Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Pfizer, Inc. Key News & Latest Developments
Table 78. Parnell Pharmaceuticals, Inc. Company Summary
Table 79. Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Product Offerings
Table 80. Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Parnell Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Acacia Pharma Company Summary
Table 83. Acacia Pharma Xerostomia Therapeutics Product Offerings
Table 84. Acacia Pharma Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Acacia Pharma Key News & Latest Developments
Table 86. OraCoat Company Summary
Table 87. OraCoat Xerostomia Therapeutics Product Offerings
Table 88. OraCoat Xerostomia Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. OraCoat Key News & Latest Developments
Table 90. Xerostomia Therapeutics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Xerostomia Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Xerostomia Therapeutics Production by Region, 2018-2023 (K Units)
Table 93. Global Xerostomia Therapeutics Production by Region, 2024-2029 (K Units)
Table 94. Xerostomia Therapeutics Market Opportunities & Trends in Global Market
Table 95. Xerostomia Therapeutics Market Drivers in Global Market
Table 96. Xerostomia Therapeutics Market Restraints in Global Market
Table 97. Xerostomia Therapeutics Raw Materials
Table 98. Xerostomia Therapeutics Raw Materials Suppliers in Global Market
Table 99. Typical Xerostomia Therapeutics Downstream
Table 100. Xerostomia Therapeutics Downstream Clients in Global Market
Table 101. Xerostomia Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Xerostomia Therapeutics Segment by Type in 2022
Figure 2. Xerostomia Therapeutics Segment by Application in 2022
Figure 3. Global Xerostomia Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Xerostomia Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Xerostomia Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. Xerostomia Therapeutics Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Xerostomia Therapeutics Revenue in 2022
Figure 9. By Type - Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 12. By Type - Global Xerostomia Therapeutics Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 16. By Application - Global Xerostomia Therapeutics Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Xerostomia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Xerostomia Therapeutics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 21. By Country - North America Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 23. US Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 28. Germany Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. France Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 37. China Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. India Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 44. Brazil Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Xerostomia Therapeutics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Xerostomia Therapeutics Sales Market Share, 2018-2029
Figure 48. Turkey Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Xerostomia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Xerostomia Therapeutics Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Xerostomia Therapeutics by Region, 2022 VS 2029
Figure 54. Xerostomia Therapeutics Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 口腔乾燥症治療薬のグローバル市場展望 2023年-2029年：スプレー、内服液、口腔錠、マウスウォッシュ
  • 同種幹細胞移植のグローバル市場展望 2023年-2029年：非改変幹細胞移植、T細胞除去移植、臍帯血移植、ドナーリンパ球注入
  • エピジェネティック治療のグローバル市場展望 2023年-2029年：PRAP（ホスホリボシルピロリン酸アミドトランスフェラーゼ）阻害剤、キナーゼ阻害剤、IDH（イソクエン酸脱水素酵素）阻害剤、HDAC（ヒストン脱アセチル化酵素）阻害剤、DNMT（DNAメチルトランスフェラーゼ）阻害剤
  • 治療用放射性リガンドのグローバル市場展望 2023年-2029年：ベータ線放出、標的アルファ療法
  • 馬獣医治療のグローバル市場展望 2023年-2029年：医薬品、ワクチン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14521 )"口腔乾燥症治療薬のグローバル市場展望 2023年-2029年：OTC、処方薬" (英文：Xerostomia Therapeutics Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。